MCPH1 and chronic myelogenous leukemia, BCR-ABL1 positive: We searched PubMed and found 16 studies identified the potential role of MCPH1/BRIT1 in different cancer types such as, lymphoma, chronic myeloid leukemia, cervical cancer, endometrial cancer, hepatocellular carcinoma, renal carcinoma, brain cancer, oral squamous cell carcinoma, melanoma and prostate cancer.